• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

130.20 +0.41 (+0.32%)
Official Closing Price Updated: 7:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
June 24, 2026
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
June 24, 2026
From BioMedWire
Via GlobeNewswire
News headline image
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer
June 24, 2026
From Merck & Co., Inc.
Via Business Wire
Uncover the latest developments among dow jones stocks in today's session. ↗
June 23, 2026
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
June 23, 2026
Via Chartmill
Which dow jones stocks are moving on Monday? ↗
June 22, 2026
Via Chartmill
Top dow jones movers in Monday's session ↗
June 22, 2026
Via Chartmill
News headline image
Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
June 22, 2026
From Merck & Co., Inc.
Via Business Wire
Stay informed with the top movers within the dow jones index on Thursday. ↗
June 18, 2026
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
June 18, 2026
Via Chartmill
News headline image
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
June 18, 2026
From Merck & Co., Inc.
Via Business Wire
Explore the top gainers and losers within the dow jones index in today's session. ↗
June 17, 2026
Via Chartmill
News headline image
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
June 17, 2026
From Merck & Co., Inc.
Via Business Wire
News headline image
3 Dividend Stocks to Hold for the Long Haul ↗
June 16, 2026
They have a habit of consistently raising their payouts. 
Via The Motley Fool
Topics Intellectual Property
Discover which dow jones stocks are making waves on Monday. ↗
June 15, 2026
Via Chartmill
News headline image
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
June 12, 2026
From Merck & Co., Inc.
Via Business Wire
Stay informed with the top movers within the dow jones index on Friday. ↗
June 12, 2026
Via Chartmill
Top dow jones movers in Friday's session ↗
June 12, 2026
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
June 11, 2026
Via Chartmill
Discover which dow jones stocks are making waves on Thursday. ↗
June 11, 2026
Via Chartmill
News headline image
Merck Animal Health to Acquire TARGAN
June 11, 2026
From Merck & Co., Inc.
Via Business Wire
Stay informed with the top movers within the dow jones index on Wednesday. ↗
June 10, 2026
Via Chartmill
News headline image
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
June 08, 2026
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
June 08, 2026
From Merck & Co., Inc.
Via Business Wire
Exploring the top movers within the dow jones index during today's session. ↗
June 08, 2026
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
June 08, 2026
Via Chartmill
News headline image
The Smartest Dividend ETF to Buy With $1,000 Right Now -- and It's Up 19% in 2026 ↗
June 06, 2026
This low-fee fund offers a glorious mix of growth and income. 
Via The Motley Fool
Topics ETFs Stocks
Friday's session: top gainers and losers in the dow jones index ↗
June 05, 2026
Via Chartmill
News headline image
Merck: Navigating the Patent Cliff and Future Growth Prospects ↗
June 04, 2026
Join us as we dissect Merck's stock potential and the challenges it faces with the impending patent cliff of Keytruda. Can this pharmaceutical giant maintain its edge in the market? 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap